Mumps

Pinehurst Physicians Spearhead Video Campaign Urging Patients to Get Vaccinated for COVID-19

Retrieved on: 
Monday, September 13, 2021

PINEHURST, N.C., Sept. 13, 2021 /PRNewswire/ -- With more than 51 percent of North Carolina still not fully vaccinated, physicians at Pinehurst Medical Clinic have spearheaded a viral video to urge community members to get vaccinated.

Key Points: 
  • PINEHURST, N.C., Sept. 13, 2021 /PRNewswire/ -- With more than 51 percent of North Carolina still not fully vaccinated, physicians at Pinehurst Medical Clinic have spearheaded a viral video to urge community members to get vaccinated.
  • According to the CDC, 10 percent of American adults fall into the "wait and see" category, and 14 percent say they aren't planning on getting vaccinated.
  • Their goal is to combat the doubt felt by an alarming percentage of Americans who remain reluctant about getting vaccinated.
  • Pinehurst Medical Clinic physicians and healthcare professionals share a commitment to patient-centered care, utilizing the latest advances in medical technology.

New Research on SINOVAC’s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant

Retrieved on: 
Thursday, September 9, 2021

Having a third dose of inactivated COVID-19 vaccine is more effective for COVID-19 prevention.

Key Points: 
  • Having a third dose of inactivated COVID-19 vaccine is more effective for COVID-19 prevention.
  • This study includes an in-depth exploration of the immunogenic profiles of antibodies from three and two-dose CoronaVac recipients and convalescents.
  • The above research provides a theoretical basis for a third dose of inactivated COVID-19 vaccine.
  • SINOVACs COVID-19 vaccine, CoronaVac, has been granted emergency use approval or conditional marketing authorization by over 50 countries or regions worldwide.

SINOVAC Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Children and Adolescents

Retrieved on: 
Wednesday, September 8, 2021

To continue protecting the population, we have approved CoronaVac for children aged six and up," Garcia said.

Key Points: 
  • To continue protecting the population, we have approved CoronaVac for children aged six and up," Garcia said.
  • CoronaVac had been approved for emergency use in the population aged from 3 to 17 years old on May 28, 2021, in China.
  • It was also approved for use in the population aged from 12 to 17 years old by Indonesian authorities in June 2021.
  • The EV71 vaccine, an innovative vaccine developed by SINOVAC against hand foot and mouth disease caused by EV71, was commercialized in China in 2016.

Columbus Metropolitan Housing Authority is the latest Ohio employer to announce a vaccination requirement, helping agency achieve a 90% compliance rate

Retrieved on: 
Wednesday, September 1, 2021

Columbus, OH, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The Columbus Metropolitan Housing Authority (CMHA) announced it began implementation of a mandatory vaccination policy for all employees that became effective Monday, Aug. 30, 2021, helping the agency reach a 90% immunization compliance rate.

Key Points: 
  • Columbus, OH, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The Columbus Metropolitan Housing Authority (CMHA) announced it began implementation of a mandatory vaccination policy for all employees that became effective Monday, Aug. 30, 2021, helping the agency reach a 90% immunization compliance rate.
  • CMHA is providing a cash incentive for all 120-plus staff members who receive the vaccine within the agencys identified timeline.
  • CMHAs introduction of the vaccination requirement follows similar announcements by numerous colleges, national retailers and other Ohio businesses that have begun to mandate vaccines.
  • Half of the authority's apartments are set aside as workforce housing for families earning 80% of the area median income.

Poll: More than One-Third of Unvaccinated Adults Say FDA Approval of Vaccines Would Address Their Safety Concerns

Retrieved on: 
Wednesday, August 25, 2021

Another 20% said it would address "some" of their concerns.The poll -- conducted August 19-22 by data intelligence company Morning Consult on behalf of the de Beaumont Foundation -- also identified messages that would make unvaccinated adults feel more confident in the vaccines following FDA approval.

Key Points: 
  • Another 20% said it would address "some" of their concerns.The poll -- conducted August 19-22 by data intelligence company Morning Consult on behalf of the de Beaumont Foundation -- also identified messages that would make unvaccinated adults feel more confident in the vaccines following FDA approval.
  • With the FDA granting full approval for a COVID-19 vaccine, Americans can be even more confident that the COVID-19 vaccines work and are safe.
  • For people who have said they will "wait and see," the results are in -- the COVID-19 vaccines work, and they're safe.
  • The Pfizer COVID-19 vaccine now has the exact same level of approval as those childhood vaccines.

Walmart Makes It Easy to Stay Healthy with Convenient Flu Shots, Now Available Nationwide

Retrieved on: 
Wednesday, August 18, 2021

Low-cost flu shots are now available in 4,600+ Walmart pharmacies nationwide via walk-up and community flu shot clinics.

Key Points: 
  • Low-cost flu shots are now available in 4,600+ Walmart pharmacies nationwide via walk-up and community flu shot clinics.
  • Walmart pharmacies across the country offer both vaccines, and customers can receive a low-cost flu and free COVID-19 vaccine at the same time, if they choose.
  • These events will make it quick, easy and convenient for customers to get flu shots in stores nationwide.
  • To learn more about the flu shots and wellness resources available at your neighborhood Walmart, please visit www.walmart.com/wellnesshub .

Universities and Colleges Prepare for the Safe Return to Campus this Fall with Kokomo24/7® Safety Cloud™ to Manage COVID-19 Vaccinations of Students, Staff, and Faculty

Retrieved on: 
Wednesday, August 11, 2021

Part of the Kokomo24/7 Safety Cloud, VaxTrax serves as a tool for accurate and secure vaccination data collection and management, as well as verification and digital proof accessibility.

Key Points: 
  • Part of the Kokomo24/7 Safety Cloud, VaxTrax serves as a tool for accurate and secure vaccination data collection and management, as well as verification and digital proof accessibility.
  • It allows an institution to efficiently compile and manage all vaccine information belonging to students, staff, and faculty.
  • The process from uploading vaccine information to receiving a verified, digital vaccine card is quick and seamless.
  • At present, nearly 1 million users have utilized one of the many health and safety features of the Kokomo24/7 Safety Cloud.

SINOVAC Announces Positive Data on Booster Shots of CoronaVac®, Induces Strong Immune Response in Adult and Elderly Populations

Retrieved on: 
Tuesday, August 10, 2021

The publications detail findings from clinical studies on the immunogenicity, safety, and immune response of CoronaVac in two- and three-dose schedules.

Key Points: 
  • The publications detail findings from clinical studies on the immunogenicity, safety, and immune response of CoronaVac in two- and three-dose schedules.
  • The results indicate that a third booster dose of CoronaVac induces a strong immune response in healthy adults with no serious adverse reactions related to the vaccine.
  • This research provides important scientific data and supplement existing research to help policymakers develop strategies for vaccine rollout and timing of booster doses.
  • In addition, a third dose was found to be well-tolerated in elderly patient populations with no vaccine-related serious adverse events reported.

Talis Appoints Jeryl Hilleman to Board of Directors

Retrieved on: 
Thursday, March 18, 2021

MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced the appointment of Jeryl Jeri Hilleman to its Board of Directors.

Key Points: 
  • MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced the appointment of Jeryl Jeri Hilleman to its Board of Directors.
  • Jeris experience and guidance will be instrumental as we continue to scale our business in preparation for the commercial launch of Talis One.
  • Ms. Hilleman brings over 20 years of executive leadership and financial experience to Talis.
  • She currently serves as Chairman of the Board of Omada Health and is a Director of Novocure, SI-Bone and Minerva Neurosciences.

Global Paediatric Vaccine Markets 2020-2025 - Rising Number of Collaborations, Expansions, and Mergers

Retrieved on: 
Wednesday, January 6, 2021

These vaccines include the DTP vaccine, MMR vaccine, polio vaccine, and meningococcal vaccine, etc.

Key Points: 
  • These vaccines include the DTP vaccine, MMR vaccine, polio vaccine, and meningococcal vaccine, etc.
  • Certain factors, such as the rising number of chronic diseases across the globe along with the global initiatives taken towards vaccine production for rare diseases, have been major drivers of growth for the pediatric market.
  • By Vaccine Type, the Monovalent Vaccine is estimated to account for the fastest-growing segment during the forecast period.
  • By Application, The Infectious Diseases Segment holds the largest share due to rising global awareness about immunization against infectious diseases that cause death.